As of 2025-05-16, the Intrinsic Value of PainReform Ltd (PRFX) is -72.50 USD. This PRFX valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.90 USD, the upside of PainReform Ltd is -3,915.92%.
Based on its market price of 1.90 USD and our intrinsic valuation, PainReform Ltd (PRFX) is overvalued by 3,915.92%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -72.50 - -72.50 | -72.50 | -3,915.92% |
| P/E | (138.34) - (188.80) | (139.93) | -7464.7% |
| DDM - Stable | (83.35) - (282.29) | (182.82) | -9722.2% |
| DDM - Multi | (35.27) - (100.91) | (53.22) | -2900.9% |
| Market Cap (mil) | 3.59 |
| Beta | 0.06 |
| Outstanding shares (mil) | 1.89 |
| Enterprise Value (mil) | -0.67 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.40% |
| Cost of Debt | 5.00% |
| WACC | 8.70% |